Report Date,2012-03-31 00:00:00,2013-03-31 00:00:00,2014-03-31 00:00:00,2015-03-31 00:00:00,2016-03-31 00:00:00,2017-03-31 00:00:00,2018-03-31 00:00:00,2019-03-31 00:00:00,2020-03-31 00:00:00,2021-03-31 00:00:00,Company_Name
Cash from Operating Activity,405.56,827.22,548.68,285.55,164.3,419.15,557.85,181.74,316.76,608.38,JUBLPHARMA
Cash from Investing Activity,-501.52,-399.45,-193.78,1319.35,521.7,-43.07,-126.93,-284.79,-197.71,116.89,JUBLPHARMA
Cash from Financing Activity,-686.4,-445.73,-360.79,-1646.65,-784.44,-338.4,-470.44,85.28,-41.05,-781.65,JUBLPHARMA
Net Cash Flow,-782.36,-17.96,-5.89,-41.75,-98.44,37.69,-39.52,-17.77,78.0,-56.38,JUBLPHARMA
